Cécile Bally

933 citations

27 papers · 435 indexed · h-index 10

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 20
- Acute Myeloid Leukemia Research 14
- Multiple Myeloma Research and Treatments 6
- Hemophilia Treatment and Research 4
Genetics 9
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 4
- Chronic Lymphocytic Leukemia Research 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3

Co-authors: Pierre Fenaux Jacqueline Lehmann‐Che Hugues de Thé Julien Mozziconacci Lionel Adès Claude Preudhomme Aline Renneville Virginie Éclache
Journals: Blood (9 papers)Leukemia Research (4 papers)Haemophilia (2 papers)Haematologica (2 papers)Journal of Thrombosis and Haemostasis (1 paper)
Partner nations: France United States Italy

In The Last Decade

Cécile Bally

24 papers receiving 432 citations

Peers

Countries citing papers authored by Cécile Bally

Since Specialization

Citations

This map shows the geographic impact of Cécile Bally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Bally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Bally more than expected).

Fields of papers citing papers by Cécile Bally

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Bally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Bally. The network helps show where Cécile Bally may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cécile Bally, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cécile Bally Line = papers co-authored together Cécile Bally links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Is primary hemostasis involved in bleeding diathesis in patients with type 1 glycogen storage disease? Thrombosis Research ·Tae-Rin kim, Yueyu Yu, Cécile Bally, Tiffany Pascreau, Anaïs Brassier, Fukuko KAKIZOE, Verkhozina Ea, Y. Tsumagari, Dominique Lasne, Pascale de Lonlay, Annie Harroche, Delphine Borgel	2025	0
2	Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network Haemophilia ·Sandrine Meunier, Annie Harroche, Antoine Rauch, Cécile Bally, Klaus Eck, Anne-Laure Leveiller, Venkat Bharath Reddy Gowni, Hérvè Chambost, Eliška Zárošská, (unknown)	2024	1
3	Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study Journal of Thrombosis and Haemostasis ·Lina Khider, Marie Templé, Cécile Bally, Scott T. Leydig, Luc Darnige, Olivier Sanchez, Benjamin Planquette, Mohd Tauheed Alam, Emmanuel Messas, David M. Smadja, Joseph Emmerich, Tristan Mirault, Olivier Kosmider, Nicolas Gendron	2022	13
4	Emicizumab does not interfere with the activated clotting time Haemophilia ·程泽华, Corinne Frère, Grant A. Edmonds, Annie Harroche, Cécile Bally, Ahmed Abbes, Roseline d’Oiron, Laurent Frenzel, Delphine Borgel, Dominique Lasne	2022	1
5	Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient Haematologica ·Annie Harroche, C. W. Sabrosky, Grant A. Edmonds, Delphine Borgel, Dominique Lasne, Caterina Casari, Ivan Peyron, Laurent Frenzel, Stéphanie Chhun, Peter J. Lenting, Cécile Bally	2021	13
6	Synergistic effects of PRIMA-1^Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia Haematologica ·Nabih Maslah, Antan Vino A, K Nam, Emmanuelle Verger, Ariel Smith, Pierre Ly, B Baraniak, M.a Elvira De Castro-López, Marie‐Hélène Schlageter, Cécile Bally, Elsa Miekoutima, Ramy Rahmé, Jacqueline Lehmann‐Che, Lionel Adès, Pierre Fenaux, Bruno Cassinat, Stéphane Giraudier	2019	100
7	Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia Nature Communications ·Jacqueline Lehmann‐Che, Cécile Bally, Éric Letouzé, Caroline Berthier, Hao Yuan, Florence Jollivet, Lionel Adès, Bruno Cassinat, Pierre Hirsch, Arnaud Pigneux, Julien Mozziconacci, Scott C. Kogan, Pierre Fenaux, Hugues de Thé	2018	33
8	Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia Leukemia ·Aline Renneville, Philippe Attias, Xavier Thomas, Cécile Bally, Sandrine Hayette, H. Farhat, Virginie Éclache, Alice Marceau‐Renaut, Bruno Cassinat, Jean Feuillard, Christine Terré, Éric Delabesse, Sophie Park, Julie Lejeune, Sylvie Chevret, Lionel Adès, Claude Preudhomme, Pierre Fenaux	2018	2
9	Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy Oncotarget ·Thomas Prébet, Thomas Cluzeau, Sophie Park, Mikkael A. Sekeres, Ulrich Germing, Lionel Adès, Uwe Platzbecker, Katharina S. Götze, Norbert Vey, Esther N. Oliva, Mary M. Sugrue, Cécile Bally, Charikleia Kelaïdi, Najla Al Ali, Pierre Fenaux, Steven D. Gore, Rami S. Komrokji	2017	17
10	Whole Exome Analysis of Relapsing Patients with Acute Promyelocytic Leukemia Blood ·Cécile Bally, Jacqueline Lehmann‐Che, Bruno Cassinat, Lionel Adès, Éric Letouzé, Pierre Hirsch, Julien Mozziconacci, Sophie Raynaud, Éric Delabesse, Madalina Uzunov, Mathilde Hunault, Éric Lippert, Hélène Lapillonne, Christophe Ferrand, Carine Gervais, Nathalie Gachard, Agnès Guerci, Pierre Fenaux, Hugues de Thé	2016	1
11	Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromes Leukemia Research ·Cécile Bally, Aline Renneville, Claude Preudhomme, Nishanth Ravi, Lionel Adès, Hugues de Thé, Pierre Fenaux, Jacqueline Lehmann‐Che	2015	2
12	Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine Leukemia Research ·Cécile Bally, Lionel Adès, Aline Renneville, Wenming Xia, Virginie Éclache, Claude Preudhomme, Julien Mozziconacci, Hugues de Thé, Jacqueline Lehmann‐Che, Pierre Fenaux	2014	122
13	Detection of TP53 Mutations in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). a Comparison Between a Functional Method (FASAY) and Next Generation Sequencing (NGS) Blood ·Cécile Bally, Aline Renneville, Lionel Adès, Claude Preudhomme, Hugues de Thé, Pierre Fenaux, Jacqueline Lehmann‐Che	2014	1
14	Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM) Leukemia Research ·Cécile Bally, Sylvain Thépot, Bruno Quesnel, Norbert Vey, François Dreyfus, Jehane Fadlallah, Pascal Turlure, Stéphane de Botton, Caroline Dartigeas, Benoît De Renzis, Raphaël Itzykson, Pierre Fenaux, Lionel Adès	2013	44
15	P-023 Incidence and prognostic value of TP53 mutations in IPSS low and INT 1 (lower risk) MDS with del 5q Leukemia Research ·Cécile Bally, Lionel Adès, Aline Renneville, Claude Preudhomme, Sophie Raynaud, Thomas Cluzeau, Virginie Éclache, Mathilde Hunault, CM ADYA, Michaëla Fontenay, Julien Mozziconacci, Hugues de Thé, Pierre Fenaux, Jacqueline Lehmann‐Che	2013	0
16	Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL Group Journal of Clinical Oncology ·Cécile Bally, Jehane Fadlallah, Guy Leverger, Yves Bertrand, Alain Robert, André Baruchel, Agnès Guerci, Christian Récher, Emmanuel Raffoux, Xavier Thomas, Thierry Leblanc, Nadia Idres, Bruno Cassinat, Norbert Vey, Christine Chomienne, Hervé Dombret, Miguel Á. Sanz, Pierre Fenaux, Lionel Adès	2012	32
17	Incidence and Prognostic Value of TP53 Mutations in Lower Risk MDS with Del 5q. Blood ·Cécile Bally, Lionel Adès, Aline Renneville, Sophie Raynaud, Virginie Éclache, Thomas Cluzeau, Mathilde Hunault, Aspasia Stamatoullas, Christian Bastard, Michaëla Fontenay, Julien Mozziconacci, Claude Preudhomme, Hugues de Thé, Pierre Fenaux, Jacqueline Lehmann‐Che	2012	1
18	Azacitidine Treatment for Lenalidomide (LEN)-Resistant Myelodysplastic Syndrome (MDS) with Del 5q Blood ·Rami S. Komrokji, Cécile Bally, Raphaël Itzykson, Sylvain Thépot, Eric Padron, Najla H. Al Ali, Jeffrey E. Lancet, Alan F. List, Pierre Fenaux, Lionel Adès	2012	9
19	Une pleurésie à éosinophiles liée à la prise d’acide valproïque Revue de Pneumologie Clinique ·Cécile Bally, Clémence Martin, Juan Gabriel Mollocana Lara, María Teresa Ripoll Echeverría, J Lacronique, Daniel Dusser, Pierre‐Régis Burgel	2011	6
20	Azacitidine (AZA) After Failure of Lenalidomide (LEN) in Low/Int-1 Risk MDS with Del 5q Blood ·Cécile Bally, Raphaël Itzykson, M.O. Sarytaeva, Kalev Kask, Virginie Siguret, Anne‐Laure Taksin, Benoît De Renzis, Laurence Legros, Xavier Thomas, Krimo Bouabdallah, Pascal Chaı̈bi, Charikleia Kelaïdi, Pierre Fenaux, Lionel Adès	2011	3

About Cécile Bally

Cécile Bally is a scholar working on Hematology, Genetics, Internal Medicine, Pharmacy and Cancer Research, having authored 27 papers that have together received 435 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Multiple Myeloma Research and Treatments (6 papers), Retinoids in leukemia and cellular processes (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Hemophilia Treatment and Research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (335 citations), Genetics (101 citations), Molecular Biology (208 citations), Internal Medicine (11 citations) and Cancer Research (42 citations). Cécile Bally has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Pierre Fenaux, Jacqueline Lehmann‐Che, Hugues de Thé, Julien Mozziconacci, Lionel Adès, Lionel Adès, Claude Preudhomme, Aline Renneville, Virginie Éclache and Bruno Cassinat. Their work appears in journals such as Blood, Leukemia Research, Haemophilia, Haematologica and Journal of Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact